Back to Treatments

Treatment

Immunoglobulin (Post-exposure prophylaxis)

1
Conditions
100
Trials
300K
Participants
78%
Average Safety

Condition Evidence

Acute hepatitis A

100 trials · 300K participants

85% effectiveness · 78% safety
Immunoglobulin (Post-exposure prophylaxis) | DFDA